Entropy multi-target QSAR model for prediction of antiviral drug complex networks

Chemometrics and Intelligent Laboratory Systems

Volumn 107, Issue 2, 2011, Pages 227-233

  Prado Prado, Francisco J ^a   García, Isela ^a   García Mera, Xerardo ^a   González Díaz, Humberto ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Department of Pharmacology   (Spain)

Author keywords

Antiviral drugs; Entropy; Linear Discriminant Analysis; Markov Chain model; QSAR

Indexed keywords

ANTIVIRUS AGENT;

ACCURACY; ANTIVIRAL ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; ENTROPY; MATHEMATICAL MODEL; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROCESS DEVELOPMENT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 79959772611     PISSN: 01697439     EISSN: 18733239     Source Type: Journal    
DOI: 10.1016/j.chemolab.2011.02.003     Document Type: Article

References (51)

1. Prado-Prado J., Martinez de la Vega O., Uriarte E., Ubeira F.M., Chou K.-C., González-Díaz H. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorg. Med. Chem. 2008, 10.1016/j.bmc.2008.11.075.
2. Fratev F., Benfenati E. 3D-QSAR and molecular mechanics study for the differences in the azole activity against yeastlike and filamentous fungi and their relation to P450DM inhibition. 1. 3-substituted-4(3H)-quinazolinones. J. Chem. Inf. Model. 2005, 45:634-644.
3. Cronin M.T., Aptula A.O., Dearden J.C., Duffy J.C., Netzeva T.I., Patel H., Rowe P.H., Schultz T.W., Worth A.P., Voutzoulidis K., Schuurmann G. Structure-based classification of antibacterial activity. J. Chem. Inf. Comput. Sci. 2002, 42:869-878.
4. Marrero-Ponce Y., Castillo-Garit J.A., Olazabal E., Serrano H.S., Morales A., Castanedo N., Ibarra-Velarde F., Huesca-Guillen A., Sanchez A.M., Torrens F., Castro E.A. Atom, atom-type and total molecular linear indices as a promising approach for bioorganic and medicinal chemistry: theoretical and experimental assessment of a novel method for virtual screening and rational design of new lead anthelmintic. Bioorg. Med. Chem. 2005, 13:1005-1020.
5. Marrero-Ponce Y., Medina-Marrero R., Torrens F., Martinez Y., Romero-Zaldivar V., Castro E.A. Atom, atom-type, and total nonstochastic and stochastic quadratic fingerprints: a promising approach for modeling of antibacterial activity. Bioorg. Med. Chem. 2005, 13:2881-2899.
6. Marrero-Ponce Y., Meneses-Marcel A., Castillo-Garit J.A., Machado-Tugores Y., Escario J.A., Barrio A.G., Pereira D.M., Nogal-Ruiz J.J., Aran V.J., Martinez-Fernandez A.R., Torrens F., Rotondo R., Ibarra-Velarde F., Alvarado Y.J. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs. Bioorg. Med. Chem. 2006, 14:6502-6524.
7. Montero-Torres A., Vega M.C., Marrero-Ponce Y., Rolon M., Gomez-Barrio A., Escario J.A., Aran V.J., Martinez-Fernandez A.R., Meneses-Marcel A. A novel non-stochastic quadratic fingerprints-based approach for the 'in silico' discovery of new antitrypanosomal compounds. Bioorg. Med. Chem. 2005, 13:6264-6275.
8. Meneses-Marcel A., Marrero-Ponce Y., Machado-Tugores Y., Montero-Torres A., Pereira D.M., Escario J.A., Nogal-Ruiz J.J., Ochoa C., Aran V.J., Martinez-Fernandez A.R., Garcia Sanchez R.N. A linear discrimination analysis based virtual screening of trichomonacidal lead-like compounds: outcomes of in silico studies supported by experimental results. Bioorg. Med. Chem. Lett. 2005, 15:3838-3843.
9. Vega M.C., Montero-Torres A., Marrero-Ponce Y., Rolon M., Gomez-Barrio A., Escario J.A., Aran V.J., Nogal J.J., Meneses-Marcel A., Torrens F. New ligand-based approach for the discovery of antitrypanosomal compounds. Bioorg. Med. Chem. Lett. 2006, 16:1898-1904.
10. Marrero-Ponce Y., Meneses-Marcel A., Rivera-Borroto O.M., Garcia-Domenech R., De Julian-Ortiz J.V., Montero A., Escario J.A., Barrio A.G., Pereira D.M., Nogal J.J., Grau R., Torrens F., Vogel C., Aran V.J. Bond-based linear indices in QSAR: computational discovery of novel anti-trichomonal compounds. J. Comput. Aid. Mol. Des. 2008, 22:523-540.
11. Garcia-Domenech R., Galvez J., de Julian-Ortiz J.V., Pogliani L. Some new trends in chemical graph theory. Chem. Rev. 2008, 108:1127-1169.
12. Marrero-Ponce Y., Khan M.T., Casanola-Martin G.M., Ather A., Sultankhodzhaev M.N., Garcia-Domenech R., Torrens F., Rotondo R. Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: aiding decision-making in 'in silico' selection of new lead tyrosinase inhibitors. J. Comput. Aid. Mol. Des. 2007, 21:167-188.
13. Garcia-Garcia A., Galvez J., de Julian-Ortiz J.V., Garcia-Domenech R., Munoz C., Guna R., Borras R. Search of chemical scaffolds for novel antituberculosis agents. J. Biomol. Screen. 2005, 10:206-214.
14. Garcia-Garcia A., Galvez J., de Julian-Ortiz J.V., Garcia-Domenech R., Munoz C., Guna R., Borras R. New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. J. Antimicrob. Chemother. 2004, 53:65-73.
15. Meneses-Marcel A., Rivera-Borroto O.M., Marrero-Ponce Y., Montero A., Machado Tugores Y., Escario J.A., Gomez Barrio A., Montero Pereira D., Nogal J.J., Kouznetsov V.V., Ochoa Puentes C., Bohorquez A.R., Grau R., Torrens F., Ibarra-Velarde F., Aran V.J. New antitrichomonal drug-like chemicals selected by bond (edge)-based TOMOCOMD-CARDD descriptors. J. Biomol. Screen. 2008, 13:785-794.
16. Vilar S., Santana L., Uriarte E. Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action. J. Med. Chem. 2006, 49:1118-1124.
17. Cruz-Monteagudo M., Borges F., Cordeiro M.N., Cagide Fajin J.L., Morell C., Ruiz R.M., Canizares-Carmenate Y., Dominguez E.R. Desirability-based methods of multiobjective optimization and ranking for global QSAR studies. Filtering safe and potent drug candidates from combinatorial libraries. J. Comb. Chem. 2008, 10:897-913.
18. González-Díaz H., Prado-Prado F.J., Santana L., Uriarte E. Unify QSAR approach to antimicrobials. Part 1: predicting antifungal activity against different species. Bioorg. Med. Chem. 2006, 14:5973-5980.
19. González-Díaz H., Prado-Prado F. Unified QSAR and network-based computational chemistry approach to antimicrobials, part 1: multispecies activity models for antifungals. J. Comput. Chem. 2008, 29:656-657.
20. Todeschini R., Consonni V. Handbook of Molecular Descriptors 2002, Wiley-VCH.
21. Gonzalez-Diaz H., Prado-Prado F., Ubeira F.M. Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach. Curr. Top. Med. Chem. 2008, 8:1676-1690.
22. González-Díaz H., Cabrera-Pérez M.A., Agüero-Chapín G., Cruz-Monteagudo M., Castañedo-Cancio N., del Río M.A., Uriarte E. Multi-target QSPR assemble of a Complex Network for the distribution of chemicals to biphasic systems and biological tissues. Chemometr. Intell. lab. 2008, 94:160-165.
23. Cruz-Monteagudo M., González-Díaz H., Agüero-Chapin G., Santana L., Borges F., Domínguez R.E., Podda G., Uriarte E. Computational chemistry development of a unified free energy Markov model for the distribution of 1300 chemicals to 38 different environmental or biological systems. J. Comput. Chem. 2007, 28:1909-1922.
24. González-Díaz H., Aguero G., Cabrera M.A., Molina R., Santana L., Uriarte E., Delogu G., Castanedo N. Unified Markov thermodynamics based on stochastic forms to classify drugs considering molecular structure, partition system, and biological species: distribution of the antimicrobial G1 on rat tissues. Bioorg. Med. Chem. Lett. 2005, 15:551-557.
25. González-Díaz H., Uriarte E. Proteins QSAR with Markov average electrostatic potentials. Bioorg. Med. Chem. Lett. 2005, 15:5088-5094.
26. Saiz-Urra L., González-Díaz H., Uriarte E. Proteins Markovian 3D-QSAR with spherically-truncated average electrostatic potentials. Bioorg. Med. Chem. 2005, 13:3641-3647.
27. Ferino G., Delogu G., Podda G., Uriarte E., González-Díaz H. Quantitative Proteome-Disease Relationships (QPDRs) in Clinical Chemistry: Prediction of Prostate Cancer with Spectral Moments of PSA/MS Star Networks. Clinical Chemistry Research 2009, Nova Science Publisher, NY. C. B.H.a.S. Mitchem (Ed.).
28. Concu R., Podda G., Uriarte E., González-Díaz H. A New Computational Chemistry & Complex Networks Approach to Structure-Function and Similarity Relationships in Protein Enzymes. Handbook of Computational Chemistry Research 2009, Nova Science Publishers. C.D. C.T.a.R. Collett (Ed.).
29. González-Díaz H., González-Díaz Y., Santana L., Ubeira F.M., Uriarte E. Proteomics, networks and connectivity indices. Proteomics 2008, 8:750-778.
30. González-Díaz H., Vilar S., Santana L., Uriarte E. Medicinal chemistry and bioinformatics-current trends in drugs discovery with networks topological indices. Curr. Top. Med. Chem. 2007, 7:1025-1039.
31. Gonzalez-Diaz H., Saiz-Urra L., Molina R., Santana L., Uriarte E. A model for the recognition of protein kinases based on the entropy of 3D van der Waals interactions. J. Proteome Res. 2007, 6:904-908.
32. González-Díaz H., Marrero Y., Hernandez I., Bastida I., Tenorio E., Nasco O., Uriarte E., Castanedo N., Cabrera M.A., Aguila E., Marrero O., Morales A., Perez M. 3D-MEDNEs: an alternative "in silico" technique for chemical research in toxicology. 1. Prediction of chemically induced agranulocytosis. Chem. Res. Toxicol. 2003, 16:1318-1327.
33. González-Díaz H., Molina R., Uriarte E. Markov entropy backbone electrostatic descriptors for predicting proteins biological activity. Bioorg. Med. Chem. Lett. 2004, 14:4691-4695.
34. Graham D.J. Information content in organic molecules: Brownian processing at low levels. J. Chem. Inf. Model. 2007, 47:376-389.
35. Graham D.J., Schacht D. Base information content in organic molecular formulae. J. Chem. Inf. Comput. Sci. 2000, 40:942.
36. Graham D.J. Information content in organic molecules: structure considerations based on integer statistics. J. Chem. Inf. Comput. Sci. 2002, 42:215.
37. Graham D.J., Malarkey C., Schulmerich M.V. Information content in organic molecules: quantification and statistical structure via Brownian processing. J. Chem. Inf. Comput. Sci. 2004, 44.
38. Graham D.J., Schulmerich M.V. Information content in organic molecules: reaction pathway analysis via Brownian processing. J. Chem. Inf. Comput. Sci. 2004, 44.
39. Graham D.J. Information content and organic molecules: aggregation states and solvent effects. J. Chem. Inf. Model. 2005, 45.
40. Prado-Prado F.J., González-Díaz H., Martinez de la Vega O., Ubeira F.M., Chou K.C. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for Input-Coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds. Bioorg. Med. Chem. 2008, 16:5871-5880.
41. Gonzalez-Diaz H., Tenorio E., Castanedo N., Santana L., Uriarte E. 3D QSAR Markov model for drug-induced eosinophilia-theoretical prediction and preliminary experimental assay of the antimicrobial drug G1. Bioorg. Med. Chem. 2005, 13:1523-1530.
42. González-Díaz H., Cruz-Monteagudo M., Molina R., Tenorio E., Uriarte E. Predicting multiple drugs side effects with a general drug-target interaction thermodynamic Markov model. Bioorg. Med. Chem. 2005, 13:1119-1129.
43. Cruz-Monteagudo M., González-Díaz H. Unified drug-target interaction thermodynamic Markov model using stochastic entropies to predict multiple drugs side effects. Eur. J. Med. Chem. 2005, 40:1030-1041.
44. Van Waterbeemd H. Discriminant Analysis for Activity Prediction. Chemometric Methods in Molecular Design 1995, 265-282. Wiley-VCH, New York. H. Van Waterbeemd (Ed.).
45. StatSoft.Inc., STATISTICA (data analysis software system), version 6.0, www.statsoft.com.Statsoft, Inc., in, 2002, pp. STATISTICA (data analysis software system), version 6.0, www.statsoft.com.Statsoft.
46. Cruz-Monteagudo M., Borges F., Cordeiro M.N. Desirability-based multiobjective optimization for global QSAR studies: application to the design of novel NSAIDs with improved analgesic, antiinflammatory, and ulcerogenic profiles. J. Comput. Chem. 2008, 29:2445-2459.
47. Haggarty S.J., Clemons P.A., Schreiber S.L. Chemical genomic profiling of biological networks using graph theory and combinations of small molecule perturbations. J. Am. Chem. Soc. 2003, 125:10543-10545.
48. Kerkvliet J., Papke L., Rodriguez M. Antiviral effects of a transgenic RNA-dependent RNA polymerase. J. Virol. 2011, 85:621-625.
49. Balzarini J., Naesens L., De Clercq E. New antivirals-mechanism of action and resistance development. Curr. Opin. Microbiol. 1998, 1:535-546.
50. Neyts J., De Clercq E. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication. Biochem. Pharmacol. 1994, 47:39-41.
51. Korba B.E., Furman P.A., Otto M.J. Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo. Expert. Rev. Anti. Infect. Theo. 2006, 4:549-561.